Utilization of fundus autofluorescence, spectral Domain optical Coherence Tomography, and enhanced depth imaging in the characterization of Bietti Crystalline dystrophy in different Stages

Retina

Volumn 35, Issue 10, 2015, Pages 2074-2084

  Li, Qian ^a   Li, Yang ^a   Zhang, Xiaohui ^a   Xu, Zhangxing ^a   Zhu, Xiaoqing ^a   Ma, Kai ^a   She, Haicheng ^a   Peng, Xiaoyan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

autofluorescence; Bietti crystalline dystrophy; choroidal neovascularization; drusen; edema.; enhanced depth imaging; outer retinal tubulation; spectral domain optical coherence tomography; stage

Indexed keywords

RANIBIZUMAB; CYP4V2 PROTEIN, HUMAN; CYTOCHROME P450;

ADULT; ALLELE; ARTICLE; AUTOFLUORESCENCE; BIETTI CRYSTALLINE DYSTROPHY; CHOROID CAPILLARY LAYER; CLINICAL ARTICLE; DYSTROPHY; EYE FUNDUS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MACULAR DEGENERATION; MACULAR EDEMA; MALE; PHOTOGRAPHY; RETINA DYSTROPHY; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL NEOVASCULARIZATION; ATROPHY; CLASSIFICATION; CORNEAL DYSTROPHIES, HEREDITARY; DRUSEN; FLUORESCENCE ANGIOGRAPHY; FLUORESCENCE IMAGING; GENETICS; MIDDLE AGED; MULTIMODAL IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA; RETINAL DISEASES; VISUAL ACUITY; YOUNG ADULT;

ADULT; ATROPHY; CHOROIDAL NEOVASCULARIZATION; CORNEAL DYSTROPHIES, HEREDITARY; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OPTICAL IMAGING; RETINA; RETINAL DISEASES; RETINAL DRUSEN; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; YOUNG ADULT;

EID: 84942419697     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000592     Document Type: Article

References (59)

1. Li A, Jiao X, Munier FL, et al. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet 2004;74:817-826.
2. Mataftsi A, Zografos L, Millá E, et al. Biettis crystalline corneoretinal dystrophy: A cross-sectional study. Retina 2004;24: 416-426.
3. Boye SE, Boye SL, Lewin AS, HauswirthWW. A comprehensive review of retinal gene therapy. Mol Ther 2013;21:509-519.
4. Yuzawa M, Mae Y, Matsui M. Biettis crystalline dystrophy. Ophthalmic Paediatr Genet 1986;7:9-20.
5. Fong AM, Koh A, Lee K, Ang CL. Biettis crystalline dystrophy in Asians: clinical, angiographic and electrophysiological characteristics. Int Ophthalmol 2009;29:459-470.
6. Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF. Fundus autofluorescence imaging: review and perspectives. Retina 2008;28:385-409.
7. Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci 2009;50:3953-3959.
8. Iriyama A, Yanagi Y. Fundus autofluorescence and retinal structure as determined by spectral domain optical coherence tomography, and retinal function in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 2012;250:333-339.
9. Ayata A, Tatlipinar S, Unal M, et al. Autofluorescence and OCT features of Biettis crystalline dystrophy. Br J Ophthalmol 2008;92:718-720.
10. Liu DN, Liu Y, Meng XH, Yin ZQ. The characterization of functional disturbances in Chinese patients with Biettis crystalline dystrophy at different fundus stages. Graefes Arch Clin Exp Ophthalmol 2012;250:191-200.
11. Halford S, Liew G, Mackay DS, et al. Detailed phenotypic and genotypic characterization of Bietti crystalline dystrophy. Ophthalmology 2014;121:1174-1184.
12. Kojima H, Otani A, Ogino K, et al. Outer retinal circular structures in patients with Bietti crystalline retinopathy. Br J Ophthalmol 2012;96:390-393.
13. Yeoh J, Rahman W, Chen F, et al. Choroidal imaging in inherited retinal disease using the technique of enhanced depth imaging optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2010;248:1719-1728.
14. Lee KY, Koh AH, Aung T, et al. Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci 2005;46:3812-3816.
15. Spaide RF, Koizumi H, Pozzoni MC, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008;146:496-500.
16. Branchini LA, Adhi M, Regatieri CV, et al. Analysis of choroidal morphologic features and vasculature in healthy eyes using spectral-domain optical coherence tomography. Ophthalmology 2013;120:1901-1908.
17. Holladay JT. Proper method for calculating average visual acuity. J Refract Surg 1997;13:388-391.
18. Staurenghi G, Sadda S, Chakravarthy U, Spaide RF. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: The INOCT consensus. Ophthalmology 2014;121:1572-1578.
19. Toto L, Carpineto P, Parodi MB, et al. Spectral domain optical coherence tomography and in vivo confocal microscopy imaging of a case of Biettis crystalline dystrophy. Clin Exp Optom 2013;96:39-45.
20. Saatci AO, Doruk HC, Yaman A. Cystoid macular edema in Biettis crystalline retinopathy. Case Rep Ophthalmol Med 2014;2014:964892.
21. Greenberg JP, Sherman J, Zweifel SA, et al. Spectral-domain optical coherence tomography staging and autofluorescence imaging in achromatopsia. JAMA Ophthalmol 2014;132:437-445.
22. Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina 2010;30:1441-1454.
23. Querques G, Guigui B, Leveziel N, et al. Insights into pathology of cuticular drusen from integrated confocal scanning laser oph-Thalmoscopy imaging and corresponding spectral domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2011;249:1617-1625.
24. Querques G, Guigui B, Leveziel N, et al. Multimodal morphological and functional characterization of Malattia Leventinese. Graefes Arch Clin Exp Ophthalmol 2013;251:705-714.
25. Kay CN, Abramoff MD, Mullins RF, et al. Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with best vitelliform macular dystrophy. Arch Ophthalmol 2012;130:357-364.
26. Kiernan DF, Shah RJ, Hariprasad SM, et al. Thirty-year follow-up of an African American family with macular dystrophy of the retina, locus 1 (North Carolina macular dystrophy). Ophthalmology 2011;118:1435-1443.
27. Rosenberg T, Roos B, Johnsen T, et al. Clinical and genetic characterization of a Danish family with North Carolina macular dystrophy. Mol Vis 2010;16:2659-2668.
28. Li Y, Tao W, Luo L, et al. CNTF induces regeneration of cone outer segments in a rat model of retinal degeneration. PLoS One 2010;5:e9495.
29. Gupta B, Parvizi S, Mohamed MD. Bietti crystalline dystrophy and choroidal neovascularisation. Int Ophthalmol 2011;31:59-61.
30. Yin H, Jin C, Fang X, et al. Molecular analysis and phenotypic study in 14 Chinese families with Bietti crystalline dystrophy. PLoS One 2014;9:e94960.
31. Mamatha G, Umashankar V, Kasinathan N, et al. Molecular screening of the CYP4V2 gene in Bietti crystalline dystrophy that is associated with choroidal neovascularization. Mol Vis 2011;17:1970-1977.
32. Nachiappan K, Krishnan T, Madhavan J. Ranibizumab for choroidal neovascular membrane in a rare case of Biettis crystalline dystrophy: A case report. Indian J Ophthalmol 2012;60:207-209.
33. Le Tien V, Atmani K, Querques G, et al. Ranibizumab for subfoveal choroidal neovascularization in Bietti crystalline retinopathy. Eye (Lond) 2010;24:1728-1729.
34. Atmaca LS, Muftuoglu O, Atmaca-Sonmez P. Peripapillary choroidal neovascularization in Bietti crystalline retinopathy. Eye (Lond) 2007;21:839-842.
35. Stefánsson E, Geirsdóttir AR, Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog Retin Eye Res 2011;30:72-80.
36. Solomon SD, Jefferys JL, Hawkins BS, et al. Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group. Retina 2009;29:1080-1090.
37. Cachulo L, Silva R, Fonseca P, et al. Early markers of choroidal neovascularization in the fellow eye of patients with unilateral exudative age-related macular degeneration. Ophthalmologica 2011;225:144-149.
38. Gass JD. Drusen and disciform macular detachment and degeneration. Trans Am Ophthalmol Soc 1972;70:409-436.
39. Broadhead GK, Chang AA. Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy. Korean J Ophthalmol 2014;28:189-191.
40. Parravano M, Sciamanna M, Giorno P, et al. Bietti crystalline dystrophy: A morpho-functional evaluation. Doc Ophthalmol 2012;124:73-77.
41. Vinores SA, Kuchle M, Derevjanik NL, et al. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization. Histol Histopathol 1995;10:913-923.
42. Wolfensberger TJ. The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol 1999;97: 387-397.
43. Kim YJ, Joe SG, Lee DH, et al. Correlations between spectraldomain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa. Invest Ophthalmol Vis Sci 2013;54:1303-1309.
44. Triolo G, Pierro L, Parodi MB, et al. Spectral domain optical coherence tomography findings in patients with retinitis pigmentosa. Ophthalmic Res 2013;50:160-164.
45. Salvatore S, Fishman GA, Genead MA. Treatment of cystic macular lesions in hereditary retinal dystrophies. Surv Ophthalmol 2013;58:560-584.
46. Murakami T, Nishijima K, Akagi T, et al. Optical coherence tomographic reflectivity of photoreceptors beneath cystoid spaces in diabetic macular edema. Invest Ophthalmol Vis Sci 2012;53:1506-1511.
47. Ramsden CM, Powner MB, Carr AJ, et al. Stem cells in retinal regeneration: past, present and future. Development 2013;140: 2576-2585.
48. Goldberg NR, Greenberg JP, Laud K, et al. Outer retinal tubulation in degenerative retinal disorders. Retina 2013;33: 1871-1876.
49. Duan L, Yamanari M, Yasuno Y. Automated phase retardation oriented segmentation of chorio-scleral interface by polarization sensitive optical coherence tomography. Opt Express 2012;20:3353-3366.
50. Zhang L, Lee K, Niemeijer M, et al. Automated segmentation of the choroid from clinical SD-OCT. Invest Ophthalmol Vis Sci 2012;53:7510-7519.
51. Hong YJ, Miura M, Makita S, et al. Noninvasive investigation of deep vascular pathologies of exudative macular diseases by high-penetration optical coherence angiography. Invest Ophthalmol Vis Sci 2013;54:3621-3631.
52. Motaghiannezam R, Schwartz DM, Fraser SE. In vivo human choroidal vascular pattern visualization using high-speed swept-source optical coherence tomography at 1060 nm. Invest Ophthalmol Vis Sci 2012;53:2337-2348.
53. Xiao X, Mai G, Li S, et al. Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy. Biochem Biophys Res Commun 2011;409:181-186.
54. Chung JK, Shin JH, Jeon BR, et al. Optical coherence tomographic findings of crystal deposits in the lens and cornea in Bietti crystalline corneoretinopathy associated with mutation in the CYP4V2 gene. Jpn J Ophthalmol 2013;57:447-450.
55. Wilson DJ, Weleber RG, Klein ML, et al. Biettis crystalline dystrophy. a clinicopathologic correlative study. Arch Ophthalmol 1989;107:213-221.
56. Kaiser-Kupfer MI, Chan CC, Markello TC, et al. Clinical biochemical and pathologic correlations in Biettis crystalline dystrophy. Am J Ophthalmol 1994;118:569-582.
57. Furusato E, Cameron J, Chan C. Evolution of cellular inclusions in Biettis crystalline dystrophy. Ophthalmol Eye Dis 2010;2:9-15.
58. Lai TY, Chu KO, Chan KP, et al. Alterations in serum fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes. Invest Ophthalmol Vis Sci 2010;51:1092-1097.
59. Mills JS. Buergers disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 2003;16:179-189.